PubMed · 1997 · 93 citations · 0 references
MedicineGeneticsOncologyCancer GeneticsMetastasisTumor ProgressionCancer CytogeneticsCancer GenomicsLoss Of HeterozygosityProstate CancerProstate PathologyProstatic PathologyChromosome 16Q LossGenetic Susceptibility To Prostate CancerLoss Of Heterozygosity AnalysisLoss Of Heterozygosity MappingMetastatic NeoplasiaProstate Cancer PrognosisProstate SpecimensTumor Grade Assessment
Several studies have indicated that in prostate cancer, frequent aberrations take place in several genomic regions. In the present study, we have analyzed allelic losses in chromosome 16 region q in 50 prostate cancer specimens of various histological grades. The most frequently deleted region was located at 16q23-16q24.2 between loci D16S504 and D16S422. The highest percentage of loss of heterozygosity (LOH) at 16q was also found within this area at loci HSD17B2 and D16S422 located at 16q24.1-q24.2. The LOH at 16q24.1-q24.2 was significantly associated with clinically aggressive behavior of the disease, metastatic disease, and higher tumor grade. Of the metastatic diseases, 83% showed LOH, whereas only 40% of the nonmetastatic diseases were found to show it. Similarly, LOH was found in 76% of the clinically aggressive diseases and in 33% of the nonaggressive diseases. The data suggest that a potentially important gene associated with prostate cancer progression is located close to 16q24.1-q24.2.